Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C Group Study

Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C Group Study

Introduction. Hepatitis C virus genotype 4 is predominant in the Middle East and Northern Africa, even if it has recently spread to Southern Europe. Data about the treatment of post-liver transplantation (LT) genotype 4 hepatitis C recurrence are scarce. We report a retrospective analysis of post-LT...

Full description

Bibliographic Details
Main Authors:	Francesca Romana Ponziani, Alessandro Milani, Antonio Gasbarrini, Raffaella Zaccaria, Raffaella Viganò, Maria Francesca Donato, Maria Cristina Morelli, Lucia Miglioresi, Luisa Pasulo, Maria Rendina, Daniele Di Paolo, Maria Marino, Pierluigi Toniutto, Stefano Fagiuoli, Maurizio Pompili
Format:	Article
Language:	English
Published:	Elsevier 2012-05-01
Series:	Annals of Hepatology
Subjects:	HCV recurrence Liver transplantation HCV treatment Genotype 4 EVR
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268119309299

Similar Items

Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens
by: Maha M Elsabaawy, et al.
Published: (2019-01-01)

PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE (SVR) TO PEGYLATED INTERFERON ALPHA (PEG-IFN α) AND RIBAVIRIN (RBV) IN PATIENTS WITH CHRONIC HEPATITIS C INFECTED WITH GENOTYPE 1.
by: Krasimir Antonov, et al.
Published: (2011-12-01)

Improvement of patient-reported outcomes in patients achieving sustained virologic response with direct-acting antivirals for hepatitis C virus infection
by: Chih-Hsun Yi, et al.
Published: (2022-08-01)

Tumour necrosis factor -308 and -238 promoter polymorphisms are predictors of a null virological response in the treatment of Brazilian hepatitis C patients
by: Tarciana Grandi, et al.
Published: (2014-06-01)

Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon
by: Sandro da Costa Ferreira, et al.

Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
by: Ramy H. Agwa, et al.
Published: (2022-02-01)

Virological and Clinical Outcome of DAA Containing Regimens in a Cohort of Patients in Calabria Region (Southern Italy)
by: Vincenzo Scaglione, et al.
Published: (2020-02-01)

Modeling the effect of HIV coinfection on clearance and sustained virologic response during treatment for hepatitis C virus
by: Ruthie Birger, et al.
Published: (2015-09-01)

Prevalence and predictors of occult hepatitis C virus infection among Egyptian patients who achieved sustained virologic response to sofosbuvir/daclatasvir therapy: a multi-center study
by: Mekky MA, et al.
Published: (2019-01-01)

Hepatitis C virus quantification in serum and saliva of HCV-infected patients
by: Gisele Barreto Lopes Menezes, et al.
Published: (2012-08-01)

Can hepatitis C virus core antigen replace quantitative RNA in the assessment of a sustained virologic response?
by: Nevine I Musa, et al.
Published: (2019-01-01)

Effect of IL-28 B Polymorphisms on Early Virological Response (EVR) in Chronic Hepatitis C Patients Treated with Interferon and Ribavirin
by: Madeeha Nazar
Published: (2016-09-01)

Virologic Tools for HCV Drug Resistance Testing
by: Slim Fourati, et al.
Published: (2015-12-01)

Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis
by: Nelson Cheinquer, et al.

Hepatitis C Virus Serologic and Virologic Tests and Clinical Diagnosis of HCV-Related Liver Disease
Published: (2006-04-01)

Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received
by: Motta Davide, et al.
Published: (2012-06-01)

Acute Hepatitis HCV genotype 3h: virological baseline characterization and monitoring “On Therapy”
by: Giuseppe Sodano, et al.
Published: (2010-12-01)

Sustained virological response after ten days of triple anti-hepatitis C virus (HCV) therapy with telaprevir plus pegylated interferon and ribavirin in an HIV/HCV co-infected cirrhotic woman
by: Hamid Hasson, et al.
Published: (2014-12-01)

Rapid Virological Response (RVR) of Daclatasvir and Sofosbuvir Plus Ribavirin in Non-Cirrhotic, Treatment-Naive Patients of Hepatitis C Virus Genotype 3
by: Muhammad Sarfraz, et al.
Published: (2018-12-01)

The distribution of hepatitis C virus genotypes in patients with hepatocellular carcinoma
by: Ayfer Bakır, et al.
Published: (2019-10-01)

Molecular evolution, virology and spatial distribution of HCV genotypes in Pakistan: A meta-analysis
by: Arslan Habib, et al.
Published: (2023-12-01)

Detection and distribution of genotypes of Hepatitis C in a tertiary care hospital
by: Upasana Bhumbla, et al.
Published: (2020-01-01)

Prevalence and Genotypic Distribution of Hepatitis C Virus in Peshawar KPK, Pakistan
by: Tanweer Kumar, et al.
Published: (2017-01-01)

Hepatitis C virus infection among Brazilian hemophiliacs: a virological, clinical and epidemiological study
by: R.A. Carmo, et al.
Published: (2002-05-01)

Soroprevalência da hepatite C em pacientes hemodialisados Hepatitis C serum prevalence in hemodialyzed patients
by: Luciano de Albuquerque Mello, et al.
Published: (2007-06-01)

Change in hepatitis C virus positivity among needle-stick injury source patients: a 10-year experience in a Japanese tertiary hospital
by: Kazuya Okushin, et al.
Published: (2021-04-01)

The Distribution of Hepatitis C Virus (HCV) Genotypes in 59 HCV Infected Patients: A Multicenter Study
by: Emine SÖNMEZ, et al.
Published: (1996-06-01)

Normalization of circulating plasma levels of miRNAs in HIV-1/HCV co-infected patients following direct-acting antiviral–induced sustained virologic response
by: Sandra Franco, et al.
Published: (2023-01-01)

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
by: Pellicelli Adriano M, et al.
Published: (2012-11-01)

Modeling HCV Disease in Animals: Virology, Immunology and Pathogenesis of HCV and GBV-B Infections
by: Cordelia eManickam, et al.
Published: (2014-12-01)

Genotyping of hepatitis C virus (HCV) in infected patients from Northeast Mexico
by: Ana María Rivas-Estilla, et al.
Published: (2008-04-01)

Do differences exist between chronic hepatitis C genotypes 2 and 3?
by: Isaura Cunha Melo, et al.

New therapies on the horizon for hepatitis C
by: Silvia C Sookoian, MD
Published: (2003-10-01)

An overview of HCV molecular biology, replication and immune responses
by: Nawaz Zafar, et al.
Published: (2011-04-01)

Hepatitis C Virus Dynamic Transmission Models Among People Who Inject Drugs
by: Woyesa SB, et al.
Published: (2023-02-01)

Clinical and epidemiological features of chronic hepatitis C in the north-western region of Ukraine
by: T. I. Bevz
Published: (2020-02-01)

Role of IL-28B polymorphisms in virologic response to combined pegylated interferon and ribavirin therapy in genotype 4 chronic HCV infected patients with and without cirrhosis
by: Amira Youssef Shaala, et al.
Published: (2015-09-01)

Rising burden of Hepatitis C Virus in hemodialysis patients
by: Naseemullah, et al.
Published: (2011-09-01)

Clinical and laboratory profiles of hepatitis C in hemophiliac children
by: Hanifah Oswari, et al.
Published: (2007-10-01)

FEATURES OF CIRCULATION OF HEPATITIS C VIRUS IN KHABAROVSK REGION
by: N. V. Soboleva, et al.
Published: (2017-06-01)